NIH Award Will Help Expand Big Data 10.20.2017
More and more often in this era of big data, it’s not a lack of information that’s the issue. Instead, it can be sorting through a tsunami of data to find what’s most relevant and meaningful to drive medical research forward. Now a $1.4 million grant from the National Institute of Health will boost efforts of a team of researchers at the University of Miami Miller School of Medicine.
Miller School’s Psychiatric Evaluation Program Finds Appropriate Treatments for Complex Conditions 10.20.2017
Angela, a 47-year-old resident of Athens, Georgia, has suffered from depression since childhood, with frequent thoughts of suicide. In the past 15 years, her doctors, who were not trained in psychiatry, prescribed approximately 20 different drugs. None were effective, and one antidepressant had serious side effects on her vision.
Buoyed by promising results of a Phase I study demonstrating the safety of mesenchymal stem cell therapy to treat frailty in older adults, researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have taken it a step further. Now Phase II randomized, placebo-controlled trial findings have verified their initial study.
A Miller School of Medicine dermatologist offers guidance to physicians diagnosing and treating leg and foot ulcers in a collaborative article published October 19 in the New England Journal of Medicine. “Chronic lower-extremity wounds affect millions worldwide, and optimizing results through evidenced-based care can improve patient outcomes, restore healthy limbs and save lives,” said Robert S. Kirsner, M.D., Ph.D.
Florida Cancer Data System at Sylvester is Again Recognized as One of the Best in the U.S. 10.18.2017
The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has received three important distinctions for the quality of its cancer registry data.
Attention Miller School of Medicine entrepreneurs: The University of Miami School of Business Administration is now accepting entries to the 2018 University of Miami Business Plan Competition, which will take place in April, 2018. The competition is open to all University of Miami students in good academic and financial standing during the current academic year.
Dr. Graham Roger Serjeant, a world-renowned researcher and authority on sickle cell disease management and care, will visit the University of Miami Miller School of Medicine on Friday, Oct. 20, to tour the Pediatric Sickle Cell Unit at UM/Jackson Memorial Hospital and make a presentation about best practices for medical professionals caring for patients with sickle cell anemia.
A six-person pediatric team from the University of Miami Miller School of Medicine traveled to Puerto Rico on October 10 to provide firsthand support for their colleagues in San Juan and two rural impoverished communities still devastated by Hurricane Maria.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have received a three-year, $1.5 million grant to study a protein known as RAGE — an acronym for Receptor for Advanced Glycation End-products — that may be a link between diabetes and breast cancer.
Big data and artificial intelligence (AI) are emerging as powerful tools for improving patient care, advancing medical research and promoting public health. But the use of large datasets of electronic health records, along with other patient information, raises a host of ethical, legal and social issues, University of Miami President Julio Frenk told a global conference hosted by UM and the World Health Organization.